Please assess the completion status of the following clinical trial:

Trial Title: Heart Failure and Risk of Re-Admissions Determined by Abnormal REVEAL Parameters

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Men and non-pregnant/non lactating women ≥ 18 years.~2. Admission to hospital or observation unit for worsening heart failure.~3. Has a Reveal XT device or has plans for a device implant for a clinical indication within 14 days of discharge.~4. Ejection fraction ≥40% by echocardiogram within 6 months of enrollment~5. Able to participate in the study for at least 6 months.~6. Not currently enrolled in another study.~7. Able to provide informed consent and complete scheduled study visits.~Exclusion Criteria:~1. Has a clinical indication for a therapeutic cardiac device (pacemaker or defibrillator)~2. History of permanent atrial fibrillation or atrial flutter.~3. History of uncontrolled hypertension (high blood pressure)~4. Has a previously implanted cardiac device (pacemaker or defibrillator) in place.~5. Stage IV or V chronic renal dysfunction (estimated GFR \<25 ml/min per 1.73 m2)~6. End-stage (Stage D) HF, including chronic ionotropic drugs infusions or left ventricular assist device~7. Waiting on the transplant list as an UNOS status 1A or 1B patient

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- REVEAL XT device (Type: None): Subjects implanted at time of admission for HF or to be implanted within 14 days of discharge from HF hospitalization for clinical indications\>

Based on this trial design, predict the completion outcome and termination type (if applicable).